These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6999441)

  • 1. Gram-negative endotoxin administration decreases hepatic drug-metabolizing enzymes during development in rats.
    Sonawane BR; Yaffe SJ
    Pediatr Res; 1980 Aug; 14(8):939-42. PubMed ID: 6999441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of neonatal androgen in the development of hepatic microsomal drug-metabolizing enzymes.
    Chung LW; Raymond G; Fox S
    J Pharmacol Exp Ther; 1975 May; 193(2):621-30. PubMed ID: 1142108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin and low protein diet induced depression of the rat hepatic drug metabolism.
    Sonawane BR; Yaffe SJ
    Pharmacology; 1983; 26(2):100-9. PubMed ID: 6844387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of certain vitamin deficiencies on hepatic drug metabolism.
    Zannoni VG; Sato PH
    Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycloheximide-induced changes in levels & distribution of hepatic microsomal enzymes of suckling rats.
    Devasagayam TP; Pushpendran CK; Eapen J
    Indian J Exp Biol; 1980 Jun; 18(6):627-30. PubMed ID: 6777294
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of hepatic microsomal mixed-function oxidase activities in rats pretreated with Nocardia rubra cell wall skeleton.
    Iwasaki K; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1982 Aug; 37(2):267-77. PubMed ID: 7134631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the decreases in hepatic cytochrome P-450 and other drug-metabolising enzymes caused by indomethacin in vivo mediated by intestinal bacterial endotoxins? 16,16-Dimethylprostaglandin F2 alpha prevents decreases in hepatic drug-metabolising enzymes due to exogenous endotoxin.
    Falzon M; Milton AS; Burke MD
    Biochem Pharmacol; 1984 Apr; 33(8):1285-92. PubMed ID: 6370266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro effect of sulfamethazine on hepatic mixed function oxidases in rats.
    Kodam KM; Govindwar SP
    Vet Hum Toxicol; 1997 Jun; 39(3):141-6. PubMed ID: 9167242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of endotoxin upon rat hepatic microsomal drug metabolism in vivo and in vitro.
    Sonawane BR; Yaffe SJ; Witmer CM
    Xenobiotica; 1982 May; 12(5):303-13. PubMed ID: 7135999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hydralazine on hepatic drug metabolizing enzymes in rats.
    Hara S; Satoh T; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):260-72. PubMed ID: 7100630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic drug metabolizing enzyme activity and tumorigenesis in mice following perinatal exposure to benzo(a)pyrene.
    Soyka LF
    Pediatr Pharmacol (New York); 1980; 1(1):85-96. PubMed ID: 6287393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of perinatal exposure of Wistar rats to l-alpha-acetylmethadol.HCl on hepatic microsomal mixed-function oxidase enzyme activity in the adult.
    Finlayson MJ; Bellward GD
    Drug Metab Dispos; 1982; 10(1):74-6. PubMed ID: 6124388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis.
    Masubuchi Y; Horie T
    Drug Metab Dispos; 2004 Apr; 32(4):437-41. PubMed ID: 15039297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of the pyrrolizidine alkaloids jacobine and monocrotaline on hepatic drug metabolising enzymes in the rat.
    Miranda CL; Cheeke PR; Buhler DR
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):573-87. PubMed ID: 6775360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic exposure to cadmium on hepatic drug metabolism.
    Dalvi RR; Robbins TJ
    J Environ Sci Health B; 1979; 14(6):603-15. PubMed ID: 512296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent defects in the hepatic monooxygenase system of adult rats exposed, perinatally, to maternally administered phenytoin.
    Shapiro BH; Lech GM; Bardales RM
    J Pharmacol Exp Ther; 1986 Jul; 238(1):68-75. PubMed ID: 3723406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cianidanol on rat hepatic monooxygenase activities.
    Beyeler S; Testa B; Perrissoud D
    Arzneimittelforschung; 1983; 33(4):564-7. PubMed ID: 6683535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
    Kato Y; Kimura R
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression of hepatic drug metabolism in endotoxin-treated and sarcoma-bearing mice.
    Bertini R; Gervasi PG; Longo V; Ghezzi P
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):223-31. PubMed ID: 1604046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.